Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Intangibles (2019 - 2025)

Biodesix's Intangibles history spans 7 years, with the latest figure at $19.0 million for Q4 2025.

  • For Q4 2025, Intangibles rose 222.95% year-over-year to $19.0 million; the TTM value through Dec 2025 reached $19.0 million, up 222.95%, while the annual FY2025 figure was $19.0 million, 222.95% up from the prior year.
  • Intangibles reached $19.0 million in Q4 2025 per BDSX's latest filing, up from $4.4 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $19.0 million in Q4 2025 to a low of $4.4 million in Q3 2025.
  • Average Intangibles over 5 years is $11.7 million, with a median of $10.0 million recorded in 2022.
  • The largest YoY upside for Intangibles was 222.95% in 2025 against a maximum downside of 71.73% in 2025.
  • A 5-year view of Intangibles shows it stood at $18.8 million in 2021, then tumbled by 47.76% to $9.8 million in 2022, then fell by 19.25% to $7.9 million in 2023, then decreased by 25.75% to $5.9 million in 2024, then skyrocketed by 222.95% to $19.0 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Intangibles are $19.0 million (Q4 2025), $4.4 million (Q3 2025), and $4.9 million (Q2 2025).